Evidence that prehypertension is a risk factor for type 2 diabetes

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 3, 2010, Pages 335-337

  Everett, Charles J ^a   Frithsen, Ivar L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Blood pressure; Insulin resistance; Metabolic syndrome; Prehypertension; Type 2 diabetes

Indexed keywords

ADULT; AGED; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; GLUCOSE TOLERANCE; HUMAN; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PREHYPERTENSION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; WAIST CIRCUMFERENCE;

AGED; BLOOD PRESSURE DETERMINATION; CAUSALITY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; REFERENCE STANDARDS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 77949452530     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.181     Document Type: Note

References (16)

1. Mullican DR, Lorenzo C, Haffner SM. Is prehypertension a risk factor for the development of Type 2 diabetes? Diabetes Care 32(10), 1870-1872 (2009).
2. Chobanian AV, Bakris GL, Black HR et al.; National High Blood Pressure Education Program Coordinating committee. The seventh report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA 289, 2560-2572 (2003).
3. Joint National committee. The sixth report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch. Intern. Med. 157, 2413-2446 (1997).
4. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch. Intern. Med. 153, 598-615 (1993).
5. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497 (2001).
6. Schmidt MI, Duncan BB, Bang H et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28, 2013-2018 (2005).
7. Mainous AG III, Diaz VA, Everett CJ. Assessing risk for development of diabetes in young adults. Ann. Fam. Med. 5, 425-429 (2007).
8. Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ. Blood pressure and risk of developing Type 2 diabetes mellitus: the Women's Health Study. Eur. Heart J. 28, 2937-2943 (2007).
9. Qureshi AI, Suri MFK, Kirmani JF et al. Is prehypertension a risk factor for cardiovascular diseases? Stroke 36, 1859-1863 (2005).
10. Hsia J, Margolis KL, Eaton CB et al. Prehypertension and cardiovascular disease risk in the Women's Health Initiative. Circulation 115, 855-860 (2007).
11. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N. Engl. J. Med. 345, 1291-1297 (2001).
12. Liszka HA, Mainous AG III, King DE, Everett CJ, Egan BM. Prehypertension and cardiovascular morbidity. Ann. Fam. Med. 3, 294-299 (2005).
13. Lorenzo C, Aung K, Stern MP, Haffner SM. Pulse pressure, prehypertension, and mortality: the San Antonio Heart study. Am. J. Hypertens. 22, 1219-1226 (2009).
14. Mainous AG III, Everett CJ, Liszka H, King DE, Egan BM. Prehypertension and mortality in a nationally representative cohort. Am. J. Cardiol. 94, 1496-1500 (2004).
15. Sequra J, Ruilope LM. Treatment of prehypertension in diabetes and metabolic syndrome: what are the pros? Diabetes Care 32(Suppl. 2), S284-S289 (2009).
16. Nilsson PM. Hypertension and diabetes: should we treat early surrogates? What are the cons? Diabetes Care 32(Suppl. 2), 290-293 (2009).